News
Hemopatch Sealing Hemostat is a ready-to-use absorbable collagen pad intended ... to achieve rapid and sustainable hemostasis in many surgical specialties. 1 General Surgeon, Prof.
3d
Zacks Investment Research on MSNBAX Stock Declines Despite Latest Product Launch Boosting Patient CareBaxter International Inc. BAX, on Thursday, announced the introduction of Hemopatch Sealing Hemostat with room temperature ...
The global hemostats market, valued at US$ 2,744.28 million in 2023, is poised to experience significant growth over the next decade, with projections indicating a market value of US$ 4,568.90 million ...
The hemostat market is projected to experience robust growth over the next decade, with the market expected to grow from a valuation of USD 78.70 million in 2022 to reach an estimated USD 134.43 ...
Inc. revealed that its LifeGel Absorbable Hemostatic Gel received the 2024/2025 Best Technology in Spine Award for its innovations in biopolymer-based hemostatic technology for surgical control of ...
Hemopatch Sealing Hemostat has offered surgeons a reliable solution for tissue sealing, dura sealing, and hemostasis,” said Steve Wallace, president, Advanced Surgery at Baxter. “The product evolution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results